{"entity":{"type":"insider","cik":"0001717996","url":"/insider/0001717996","json_url":"/insider/0001717996.json","name":"TUMOLO ANNETTE","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":6,"first":"2018-12-12","last":"2021-11-15","span_basis":"filed_date"},"name_variants":[{"name":"TUMOLO ANNETTE","source":"filing","n_filings":6,"first_seen":"2018-12-12","last_seen":"2021-11-15"}],"transactions":[{"id":4986247,"accession":"0001062993-21-010826","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001062993-21-010826","line_url":"/filing/0001062993-21-010826#line-10","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO-RAD LABORATORIES, INC.","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001717996","owner_name":"TUMOLO ANNETTE","owner_display_name":"TUMOLO ANNETTE","owner_url":"/insider/0001717996","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4800.0,"shares_display":"4,800","price_per_share":750.05,"price_display":"750.05","price_state":"stated","total_value":3600240.0,"total_display":"3,600,240.00","total_whole":"3,600,240","shares_owned_after":4593.3476,"shares_owned_after_display":"4,593.35","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-12","filed_date":"2021-11-15","scope":"insider"},{"id":4986236,"accession":"0001062993-21-010826","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-21-010826","line_url":"/filing/0001062993-21-010826","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO-RAD LABORATORIES, INC.","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001717996","owner_name":"TUMOLO ANNETTE","owner_display_name":"TUMOLO ANNETTE","owner_url":"/insider/0001717996","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1546.0,"shares_display":"1,546","price_per_share":749.0023027166882,"price_display":"749.00","price_state":"stated","total_value":1157957.56,"total_display":"1,157,957.56","total_whole":"1,157,958","shares_owned_after":5093.3476,"shares_owned_after_display":"5,093.35","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-11","filed_date":"2021-11-15","scope":"insider","n_lines":3},{"id":5094847,"accession":"0001062993-21-007992","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-21-007992","line_url":"/filing/0001062993-21-007992#line-1","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO-RAD LABORATORIES, INC.","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001717996","owner_name":"TUMOLO ANNETTE","owner_display_name":"TUMOLO ANNETTE","owner_url":"/insider/0001717996","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":792.58,"price_display":"792.58","price_state":"stated","total_value":475548.0,"total_display":"475,548.00","total_whole":"475,548","shares_owned_after":3099.3476,"shares_owned_after_display":"3,099.35","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-26","filed_date":"2021-08-27","scope":"insider"},{"id":2794791,"accession":"0001062993-20-005478","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-20-005478","line_url":"/filing/0001062993-20-005478","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO-RAD LABORATORIES, INC.","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001717996","owner_name":"TUMOLO ANNETTE","owner_display_name":"TUMOLO ANNETTE","owner_url":"/insider/0001717996","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":640.7210833333334,"price_display":"640.72","price_state":"stated","total_value":768865.3,"total_display":"768,865.30","total_whole":"768,865","shares_owned_after":4368.3476,"shares_owned_after_display":"4,368.35","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-06","filed_date":"2020-11-10","scope":"insider","n_lines":3},{"id":7850875,"accession":"0001652252-19-000075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001652252-19-000075","line_url":"/filing/0001652252-19-000075#line-1","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO-RAD LABORATORIES, INC.","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001717996","owner_name":"TUMOLO ANNETTE","owner_display_name":"TUMOLO ANNETTE","owner_url":"/insider/0001717996","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":522.0,"shares_display":"522","price_per_share":330.0,"price_display":"330.00","price_state":"stated","total_value":172260.0,"total_display":"172,260.00","total_whole":"172,260","shares_owned_after":2410.3476,"shares_owned_after_display":"2,410.35","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-12","filed_date":"2019-09-16","scope":"insider"},{"id":8489384,"accession":"0001652252-19-000049","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001652252-19-000049","line_url":"/filing/0001652252-19-000049#line-3","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO-RAD LABORATORIES, INC.","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001717996","owner_name":"TUMOLO ANNETTE","owner_display_name":"TUMOLO ANNETTE","owner_url":"/insider/0001717996","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":371.0,"shares_display":"371","price_per_share":340.0,"price_display":"340.00","price_state":"stated","total_value":126140.0,"total_display":"126,140.00","total_whole":"126,140","shares_owned_after":1917.3476,"shares_owned_after_display":"1,917.35","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-06","filed_date":"2019-09-09","scope":"insider"},{"id":6368440,"accession":"0001652252-18-000091","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001652252-18-000091","line_url":"/filing/0001652252-18-000091","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO-RAD LABORATORIES, INC.","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001717996","owner_name":"TUMOLO ANNETTE","owner_display_name":"TUMOLO ANNETTE","owner_url":"/insider/0001717996","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2376.0,"shares_display":"2,376","price_per_share":254.5050505050505,"price_display":"254.51","price_state":"stated","total_value":604704.0,"total_display":"604,704.00","total_whole":"604,704","shares_owned_after":1504.3476,"shares_owned_after_display":"1,504.35","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-11","filed_date":"2018-12-12","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000012208","name":"BIO-RAD LABORATORIES, INC.","url":"/issuer/0000012208","role":"Officer (Executive Vice President)","n_filings":6,"first_seen":"2018-12-12","last_seen":"2021-11-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001717996","retrieved_at":"2026-08-26T10:17:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}